Nasαsyn (Xylometazoline Hydrochloride, Dexpanthenol)

Xylometazoline Hydrochloride/Dexpanthenol, the active ingredient in Nasαsyn, is a nasal decongestant and mucosal protectant presented as a nasal spray for intranasal use. It relieves nasal congestion associated with rhinitis and promotes mucosal healing. GNH USA supplies Nasαsyn as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nasαsyn, containing xylometazoline and dexpanthenol, is indicated for conditions that cause nasal congestion within the rhinitis disease family.

Acute viral rhinitis: reduces nasal blockage and improves airflow. Allergic rhinitis: alleviates congestion and nasal swelling. Common cold: eases nasal congestion and promotes mucosal comfort.

Nasαsyn may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of the nasal mucosa - Sneezing - Mild headache - Transient epistaxis (nosebleed) - Unpleasant taste

Serious or Rare Side Effects: - Severe hypertension or hypertensive crisis - Tachycardia or arrhythmia - Allergic reactions including anaphylaxis - Persistent nasal ulceration - Rebound congestion with prolonged use - Vision disturbances (rare)

Before using Nasαsyn, consider the following safety measures.

Pregnancy: consult a healthcare professional before use. Breastfeeding: discuss potential risks with a physician. Duration of use: limit to 3‑5 days to avoid rebound congestion. Cardiovascular disease: use with caution in patients with hypertension or heart disease. Children: not recommended for infants unless specifically advised by a clinician. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nasαsyn can interact with other medications; review the following categories.

Major Interactions (Avoid): - Concurrent use of other nasal decongestants: additive vasoconstriction may increase risk of hypertension. - Systemic sympathomimetic agents (e.g., pseudoephedrine): may cause excessive cardiovascular stimulation. - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive episodes.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs: nasal decongestant may reduce their effectiveness. - Beta‑blockers: monitor blood pressure and heart rate. - Tricyclic antidepressants: possible additive sympathomimetic effects.